Stocks to Watch: Sherwin-Williams Company, Avanir Pharmaceuticals, Harris Corporation, Delcath Systems

Lakeway, NY -- (SBWIRE) -- 02/26/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Sherwin-Williams Company (NYSE:SHW) declined 2.22% and closed at $154.34. The Company has reached a settlement deal with the U.S. Department of Labor related to the U.S. paint maker's employee stock ownership plan by making a one-time payment of $80 million to the plan. The Company the payment will result in an after-tax charge to earnings of $49.2 million, or 47 cents per share, in its fourth quarter, ended December 31, 2012.

Is SHW a Strong Buy After The Recent Gain? Let’s Find out Here

Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) closed at $2.73. Avanir Pharmaceuticals announced that company management will present an overview of the company at the RBC Capital Markets' 2013 Global Healthcare Conference on February 26, 2013. Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need.

Is AVNR a Strong Buying Opportunity After The Recent Slump? Find out Here

Harris Corporation (NYSE:HRS) decreased 1.83% and closed at $47.10. The Board of Directors of Harris Corporation has declared a quarterly cash dividend of 37 cents per share on the common stock, payable March 20, 2013 to shareholders of record March 7, 2013. Harris Corporation together with its subsidiaries, is an international communications and information technology company serving government and commercial markets in more than 125 countries.

Should Investors Consider HRS After The Recent price Action? Get Free Trend Analysis Here

Delcath Systems, Inc. (NASDAQ:DCTH) closed at $1.47. So far this year, the stock is up over 20%. The 52-week range for the stock is $1.01 and $4.74. Delcath Systems, Inc. is a development-stage, specialty pharmaceutical and medical device company, focused on oncology, initially cancers in the liver.

Get latest News, Updates on DCTH Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.